L-Arginine Metabolism in Essential Hypertension
NCT00137124
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Essential Hypertension
Interventions
DRUG:
L-Arginine
Sponsor
University of Erlangen-Nürnberg Medical School